Prognose und Therapie der Meningitis im Kindesalter nach der 6. Lebenswoche

  • H. Isenberg

Zusammenfassung

Die bei der Meningitis im Vergleich zu anderen bakteriellen Infektionen deutlich schlechtere Prognose ist hauptsächlich auf die Tatsache zurückzuführen, daβ die Infektion in einem Kompartiment mit beeinträchtigter Immunabwehr stattfindet, wobei alle Abwehrsysteme (zellulär, humoral, Komplement) inadäquat funktionieren. Die wesentlichen Charakteristika dieser gefährlichen Krankheit sind in Tabelle 9.1 festgehalten.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    American Academy of Pediatrics (1994) Report of the Committee on infectious diseases A. Dexame-thasone therapy for bacterial meningitis in infants and children. Red Book, pp 558-559Google Scholar
  2. 2.
    Arditi M, Abies L, Yogev R (1989) Cerebrospinal Fluid Endotoxin Levels in Children with H. influen-zae Meningitis before and after Administration of Intravenous Ceftriaxone. The Journal of infectious diseases. Vol 160, No 6, December 1989, pp 1005–11PubMedCrossRefGoogle Scholar
  3. 3.
    Arguedas AG, Marks MI (1991) Recent advances in the treatment of meningitis, including steroids. Curr Opinion Infect Dis, No 4: 491–499CrossRefGoogle Scholar
  4. 4.
    Belsey MA, Hoffpanir CW, Smith MH (1969) Dexamethasone in the treatment of acute bacterial meningitis: The effect of study design on the interpretation of results. Pediatrics 44: 503–512PubMedGoogle Scholar
  5. 5.
    De Lemos RA, Haggerty RJ (1969) Corticosteroids as an adjunct to treatment in bacterial meningitis. Pediatrics 44: 30–34Google Scholar
  6. 6.
    Gaillard J-L, Abadie V, Cheron G et al. (1994) Concentrations of Ceftriaxone in Cerebrospinal Fluid of Children with Meningitis Receiving Dexamethasone Therapy. Antimicrob Agents Chemother 38: 1209–1210PubMedGoogle Scholar
  7. 7.
    Girgis NI, Farid Z, Mikhail IA et al. (1989) Dexamethasone treatment for bacterial meningitis in children and adults. Pediatr Infect Dis J 8 12: 848–851CrossRefGoogle Scholar
  8. 8.
    Girgis NI, Farid Z, Kilpatrick ME, Bishai E (1990) Dexamethasone for the treatment of children and adults with bacterial meningitis. Rev Infect Dis 12: 963–964PubMedCrossRefGoogle Scholar
  9. 9.
    Harvey DR, Stevens J (1995) What is the Role of Corticosteroids in Meningitis? Drugs 50: 945–950PubMedCrossRefGoogle Scholar
  10. 10.
    Havens PL, Wendelberger KJ, Hoffmann GM et al. (1989) Corticosteroids as adjunctive therapy in bacterial meningitis. American Journal of Diseases of Children 143: 1051–1055PubMedGoogle Scholar
  11. 11.
    Helwig H, Noack R (1993) Dexamethason bei bakterieller Meningitis. Chemotherapie J 2: 78Google Scholar
  12. 12.
    Hockaday JM, Smith HMV (1966) Corticosteroids as an adjuvant to the chemotherapy of tuberculous meningitis. Tubercle 47: 75–91PubMedCrossRefGoogle Scholar
  13. 13.
    Isenberg H (1992) Corticoid-Therapie der bakteriellen Meningitis. Sozialpädiatrie 14: 534–537Google Scholar
  14. 14.
    Jafari HS, McCracken GH (1994) Dexamethasone Therapy in Bacterial Meningitis. Ped Ann 23: 82–88Google Scholar
  15. 15.
    Kanra GY, Özen H, Seçmeer G et al. (1955) Beneficial effects of dexamethasone in children with pneumococcal meningitis. Pediatr Infect Dis J 14: 490–4Google Scholar
  16. 16.
    Kaplan SL (1989) Dexamethasone for children with bacterial meningitis. Amer J Dis Child 143: 290–292PubMedGoogle Scholar
  17. 17.
    Kaplan SL (1990) Corticosteroids and bacterial meningitis. Scand J Infect Dis 73: 43–54Google Scholar
  18. 17a.
    Kaplan SL (1997) Prevention of hearing loss from meningitis. The Lancet 350: 158–159CrossRefGoogle Scholar
  19. 18.
    Kennedy WA, Hoyt MJ, McCracken GH (1991) The role of corticosteroid therapy in children with pneumococcal meningitis. Amer J Dis Child 145: 1374–1378PubMedGoogle Scholar
  20. 19.
    Kilpi T, Peltola H, Jauhiainen T, Kallio MJT and The Finnish Study Group (1995) Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. Pediatr Infect Dis J 14: 270–8PubMedCrossRefGoogle Scholar
  21. 20.
    King SM, Law B, Langley JM et al. (1994) Dexamethasone therapy for bacterial meningitis: Better never than late? Can J Infect Dis 5: 210–215Google Scholar
  22. 21.
    Klass PE, Klein JO (1992) Therapy of bacterial sepsis, meningitis and otitis media in infants and children: 1992 poll of directors of programs in pédiatric infectious diseases. Pediatr Infect Dis J 11: 702–705PubMedCrossRefGoogle Scholar
  23. 22.
    Kornberg AE, Welliver RC, Duffy LC et al. (1991) Should corticosteroids be used in the treatment of bacterial meningitis? Pro and con. Pédiatrie Emergency Care 7: 234–241Google Scholar
  24. 23.
    Kornelisse RF, de Groot R, Neijens HJ (1995) Bacterial meningitis: mechanisms of disease and therapy. Eur J Pediatr 154: 85–96PubMedCrossRefGoogle Scholar
  25. 24.
    Lebel MH (1992) Dexamethasone therapy of bacterial meningitis. In: Schönfeld H, Helwig H (eds): Bacterial meningitis. Antibiot Chemother Basel, Karger, Vol 45, pp 169–183Google Scholar
  26. 25.
    Lebel MH (1992) Adverse outcome of bacterial meningitis due to delayed sterilization of cerebrospi-nal fluid. In: Schönfeld H, Helwig H (eds): Bacterial meningitis. Antibiot Chemother Basel, Karger, Vol 45, pp 226–238Google Scholar
  27. 26.
    Lebel MH, Hoyt MJ, Waagner DC et al. (1989) Magnetic resonance imaging and dexamethasone therapy for bacterial meningitis. Amer J Dis Child 143: 301–306PubMedGoogle Scholar
  28. 27.
    Lebel MH, Freij BJ, Syrogiannopoulos GA, Chrane DF, Hoyt MJ, Stewart SM, Kennard BD, Olsen KD, McCracken GH (1988) Dexamethasone therapy for bacterial meningitis. New Engl J Med 319 No 15: 964–971CrossRefGoogle Scholar
  29. 28.
    Lebel MH, Hoyt MJ, McCracken jr GH (1989) Comparative efficacy of ceftriaxone and cefuroxime for treatment of bacterial meningitis. J Pediatrics 114: 1049–1054CrossRefGoogle Scholar
  30. 29.
    Lepper MH, Spies HW (1957–1958) The use of intravenous hydrocortisone as supplemental treatment in acute bacterial meningitis. Antibiotics Annual 336-349Google Scholar
  31. 30.
    Marget W(1989) Dexamethason-Therapie bei „bakterieller“ Meningitis? Fortschr Med 107: 510–511Google Scholar
  32. 31.
    McCracken GH, Lebel MH (1989) Dexamethasone therapy for bacterial meningitis in infants and children. Amer J Dis Child 143: 287–289PubMedGoogle Scholar
  33. 32.
    McGowan jr JE, Chesney PJ, Crossley KB, LaForce FM (1992) Guidelines for the Use of Systemic Glucocorticosteroids in the Management of Selected Infections. J Infect Dis 165: 1–13PubMedCrossRefGoogle Scholar
  34. 33.
    Mertsola J, Ramilo O, Mustafa MM et al. (1989) Release of endotoxin after antibiotic treatment of gramnegative bacterial meningitis. Pediatr Infect Dis J 8: 904–906PubMedCrossRefGoogle Scholar
  35. 34.
    Mustafa MM, Ramilo O, Mertsola J, Risser RC et al. (1989) Modulation of inflammation and cachec-tin activity in relation to treatment of experimental hemophilus influenzae type b meningitis. J Infectious Diseases 160: 818–825CrossRefGoogle Scholar
  36. 35.
    Mustafa MM, Lebel MH, Ramilo O, Olson KD et al. (1989) Correlation of interleukin-l-beta and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis. J Pediat 115: 208–213PubMedCrossRefGoogle Scholar
  37. 36.
    Mustafa MM, Ramilo O, Sáez-Llorens X et al. (1990) Cerebrospinal fluid prostaglandins, interleukin 1 beta, and tumor necrosis factor in bacterial meningitis. Amer J Dis Child 144: 883–887PubMedGoogle Scholar
  38. 37.
    Odio CM, Faingezicht I, Salas JL, Guevara J, Mohs E, McCracken GH (1986) Cefotaxime vs, conventional therapy for the treatment of bacterial meningitis of infants and children. Pediatr Infect Dis 5: 402–407PubMedCrossRefGoogle Scholar
  39. 38.
    Odio CM, McCracken GH (1991) The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med 324: 1525–1531PubMedCrossRefGoogle Scholar
  40. 39.
    Paris MM, Hickey SM, Uscher MI et al. (1994) Effect of Dexamethasone on Therapy of Experimental Penicillin-and Cephalosporin-Resistant Pneumococcal Meningitis. Antimicrob Agents Chemother 38: 1320–1324PubMedGoogle Scholar
  41. 40.
    Prober CG (1995) The Role of Steroids in the Management of Children with Bacterial Meningitis. Pediatrics 95: 29–31PubMedGoogle Scholar
  42. 41.
    Roos KL (1990) Dexamethasone and nonsteroidal anti-inflammatory agents in the treatment of bacterial meningitis. Clinical Therapeutics 12: 290–296PubMedGoogle Scholar
  43. 42.
    Ruf B, Pohle HD (1982) Adjuvante Steroid-Therapie der bakteriellen Meningitis. Münch Med Wschr 124: 332Google Scholar
  44. 43.
    Sàez-Llorens X, Ramilo O, Mustafa MM, Mertsola J et al. (1989) Modulation of meningeal inflammation treatment with pentoxifylline. Pediatr Infect Dis J 8: 922–923PubMedCrossRefGoogle Scholar
  45. 44.
    Schaad UB, Lips U, Gnehm HE (1993) Dexamethasone therapy for bacterial meningitis in children. The Lancet, August 21, pp 457-461Google Scholar
  46. 45.
    Schaad UB, Kaplan SL, McCracken Jr GH (1995) Steroid Therapy for Bacterial Meningitis. Clin Infect Dis 20: 685–90PubMedCrossRefGoogle Scholar
  47. 46.
    Syrogiannopoulos GA, Olsen KD, Reisch JS, McCracken GH jr (1987) Dexamethasone in the treatment of experimental haemophilus influenzae type b meningitis. J Infectious Diseases 155: 213–219CrossRefGoogle Scholar
  48. 47.
    Syrogiannopoulos GA, Lourida AN, Theodoridou MC et al. (1994) Dexamethasone Therapy for Bacterial Meningitis in Children: 2-versus 4-Day Regimen. J Infect Dis 169: 853–8PubMedCrossRefGoogle Scholar
  49. 48.
    Tarlow MJ, McCracken GH (1989) Steroids in meningitis. Brit J Hosp Med 42: 358Google Scholar
  50. 49.
    Täuber MG, Shibl AM, Hackbarth CJ, Larrick JW, Sande MA (1987) Antibiotic therapy, endotoxin concentration in cerebrospinal fluid and brain edema in experimental escherichia coli meningitis in rabbits. The Journal of Infectious Diseases 156: 456–462PubMedCrossRefGoogle Scholar
  51. 50.
    Täuber MG, Sande MA (1989) Dexamethasone in bacterial meningitis: increasing evidence for a beneficial effect. Pediatr Infect Dis J 8: 842–845PubMedCrossRefGoogle Scholar
  52. 51.
    The Meningitis Working Party of the British Pédiatric Immunology and Infectious Diseases Group (1992) Should we use dexamethasone in meningitis? Archieves of Disease in Childhood 67: 1398–1401CrossRefGoogle Scholar
  53. 52.
    Townsend GC, Scheid WM (1993) Adjunctive Therapy for Bacterial Meningitis: Rationale for Use, Current Status, and Prospects for the Future. Clin Infect Dis 17 (Suppl 2): 537–49CrossRefGoogle Scholar
  54. 53.
    Tuomanen E (1992) Adjunctive therapy of experimental meningitis: Agents other than steroids. In: Schönfeld H, Helwig H (eds): Bacterial meningitis. Antibiot Chemother, Basel, Karger, vol 45, pp 184–191Google Scholar
  55. 54.
    Tuomanen E, Hengstler B, Rich R, Bray MA, Zak O, Tomasz A (1987) Nonsteroidal anti-inflammatory agents in the therapy for experimental pneumococcal meningitis. J Infectious Diseases 155: 985–990CrossRefGoogle Scholar
  56. 55.
    Tuomanen E, Saukkonouk A, Sande S et al. (1989) Reduction of inflammation, tissue damage and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes. J Exp Med 170: 959–969PubMedCrossRefGoogle Scholar
  57. 56.
    Tuomanen E (1994) Modulation of inflammation in bacterial meningitis. Isr J Med Sci 30: 339–341PubMedGoogle Scholar
  58. 57.
    Waagner DC, Kennedy WA, Hoyt MJ, McCracken GH (1990) Lack of adverse effects of dexamethasone therapy in aseptic meningitis. Pediatr Infect Dis J 9: 922–923PubMedGoogle Scholar
  59. 58.
    Wald EK, Kaplan SL, Mason jr EO et al. (1995) Dexamethasone Therapy for Children With Bacterial Meningitis. Pédiatrie 95: 21–31Google Scholar
  60. 59.
    Wees J v, Tegtmeyer KFC (1993) Stellenwert der Dexamethasontherapie bei der bakteriellen Meningitis. Monatsschr Kinderheilk 141: 732–735Google Scholar
  61. 60.
    Wenzel RP, Pinsky MR, Ulevitch RJ, Young L (1996) Current Understanding of Sepsis. Clin Infec Dis 22: 407–13CrossRefGoogle Scholar
  62. 61.
    Zabel P, Schade FU, Schlaak M (1992) Pentoxifyllin—ein Synthesehemmer für Tumor-Nekrose-Faktor-alpha. Immun Infekt 20: 80–83PubMedGoogle Scholar

Copyright information

© Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt 1998

Authors and Affiliations

  • H. Isenberg
    • 1
  1. 1.Perinatalzentrum an den Darmstädter Kinderkliniken Prinzessin MargaretDarmstadtDeutschland

Personalised recommendations